Rosiglitazone is associated with mortality in chronic hemodialysis patients.
Ramirez SP, Albert JM, Blayney MJ, Tentori F, Goodkin DA, Wolfe RA, Young EW, Bailie GR, Pisoni RL, Port FK.
Ramirez SP, et al. Among authors: pisoni rl.
J Am Soc Nephrol. 2009 May;20(5):1094-101. doi: 10.1681/ASN.2008060579. Epub 2009 Apr 8.
J Am Soc Nephrol. 2009.
PMID: 19357257
Free PMC article.